4.2 Article

Home-based respiratory rehabilitation in adult patients with moderate or severe persistent asthma

Journal

JOURNAL OF ASTHMA
Volume 51, Issue 5, Pages 552-558

Publisher

TAYLOR & FRANCIS LTD
DOI: 10.3109/02770903.2014.885039

Keywords

Asthma; home-based pulmonary rehabilitation; physical activity; therapeutic education

Ask authors/readers for more resources

Objective: We assessed retrospectively the feasibility of a home-based respiratory rehabilitation (RR) program for asthmatics under optimal pharmacological treatment, as this type of care can reduce costs and offer a more patient-friendly approach for subjects with persistent asthma. Methods: Fifty-two patients with persistent asthma were recruited to the RR program (20 males, 32 females, 54 +/- 11 (SD) years, forced expiratory volume in one second 71 +/- 33% of predicted mean value, BMI 29.9 +/- 7.9 kg/m(2)). This two-month protocol comprised education sessions, respiratory physiotherapy and an exercise training program at home and in groups supervised by an adapted physical activity instructor. Results: Thirty-nine patients completed the whole RR program, i.e. 25% dropout. The dropout rate was significantly higher with respect to younger patients in employment. The number of exacerbations decreased significantly during the year following the program, regardless of whether the patients had dropped out (p < 0.02) or not (p < 0.001). The distance walked during a 6-min walking test increased by 33m (p < 0.001). Several indices measured during a cycle ergometer test increased significantly after RR: peak oxygen uptake (10%), oxygen uptake at ventilatory threshold (12%) and maximum load (19%), all at a similar maximum heart rate. Concerning quality of life assessment, the Short-Form-36 Item Health Survey revealed a non-significant improvement in the health change'' item after RR (p < 0.07). Conclusions: This study demonstrates the potential of a home-based program in the treatment and rehabilitation of patients with asthma. Both functional and physiologic indices improved during the follow-up period.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Editorial Material Allergy

Is CCL18 a potential biomarker of type-2 asthma endotypes?

Helen Fouquet, Jonathan Giovannelli, Patricia de Nadai, Joanne Balsamelli, Patrick Berger, Arnaud Bourdin, Pascal Chanez, Stephanie Fry, Thierry Perez, Antoine Magnan, Marina Pretolani, Camille Taille, Anne Tsicopoulos, Cecile Chenivesse

Summary: This exploratory study suggests that CCL18 may not be an effective biomarker for allergic asthma endotype, but may be associated with tissue eosinophilia.

JOURNAL OF ASTHMA (2022)

Article Allergy

Benralizumab improves symptoms of patients with severe, eosinophilic asthma with a diagnosis of nasal polyposis

Giorgio Walter Canonica, Tim W. Harrison, Pascal Chanez, Francesco Menzella, Renaud Louis, Borja G. Cosio, Njira L. Lugogo, Arjun Mohan, Annie Burden, Esther Garcia Gil

Summary: The study showed that benralizumab can improve symptoms of NP and asthma outcomes in patients with severe, eosinophilic asthma and NP, with better effects observed in patients with high baseline SNOT-22 scores.

ALLERGY (2022)

Article Allergy

Mapping atopic dermatitis and anti-IL-22 response signatures to type 2-low severe neutrophilic asthma

Yusef Eamon Badi, Ana B. Pavel, Stelios Pavlidis, John H. Riley, Stewart Bates, Nazanin Zounemat Kermani, Richard Knowles, Johan Kolmert, Craig E. Wheelock, Sally Worsley, Mohib Uddin, Kjell Alving, Per S. Bakke, Annelie Behndig, Massimo Caruso, Pascal Chanez, Louise J. Fleming, Stephen J. Fowler, Urs Frey, Peter Howarth, Ildiko Horvath, Norbert Krug, Anke H. Maitland-van der Zee, Paolo Montuschi, Graham Roberts, Marek Sanak, Dominick E. Shaw, Florian Singer, Peter J. Sterk, Ratko Djukanovic, Sven-Eric Dahlen, Yi-Ke Guo, Kian Fan Chung, Emma Guttman-Yassky, Ian M. Adcock

Summary: The disease signature identified in atopic dermatitis (AD) can also be seen in adults with severe asthma, and the transcriptomic signature of AD patients who respond to anti-IL-22 therapy is enriched in severe asthma. The AD disease signature is enriched in the blood and sputum of patients with asthma and is correlated with the severity of asthma. The FZ-response signature is enriched in the blood and sputum of asthmatic patients and is correlated with the presence of neutrophils and mixed granulocytes in the sputum.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2022)

Editorial Material Allergy

Immediate Hypersensitivity to Mealworm and Cricket: Beyond Shrimp and House Dust Mite Cross-Reactivity

F. Mankouri, Y. Sereme, M. Michel, R. Piarroux, L. Pahus, P. Chanez, J. Vitte, M. Gouitaa

JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY (2022)

Article Allergy

EAACI position paper on the clinical use of the bronchial allergen challenge: Unmet needs and research priorities

Ioana Agache, Dario Antolin-Amerigo, Frederic de Blay, Cristina Boccabella, Cristiano Caruso, Pascal Chanez, Mariana Couto, Ronina Covar, Serge Doan, Jean-Luc Fauquert, Gail Gauvreau, Alina Gherasim, Ludger Klimek, Catherine Lemiere, Parameswaran Nair, Inigo Ojanguren, David Peden, Luis Perez-de-Llano, Oliver Pfaar, Carmen Rondon, Maia Rukhazde, Joaquin Sastre, Johannes Schulze, Diana Silva, Susan Tarlo, Sanna Toppila-Salmi, Jolanta Walusiak-Skorupa, Stefan Zielen, Ibon Eguiluz-Gracia

Summary: Allergic asthma is a common asthma phenotype that requires IgE sensitization to aeroallergens for diagnosis. However, current protocols for bronchial allergen challenge are not suitable for moderate-to-severe asthmatics or clinical practice. Correct diagnosis of allergic asthma can aid in selecting patients for immunomodulatory therapies, such as allergen sublingual immunotherapy.

ALLERGY (2022)

Article Critical Care Medicine

Association of Differential Mast Cell Activation with Granulocytic Inflammation in Severe Asthma

Angelica Tiotiu, Yusef Badi, Nazanin Zounemat Kermani, Marek Sanak, Johan Kolmert, Craig E. Wheelock, Philip M. Hansbro, Sven-Erik Dahlen, Peter J. Sterk, Ratko Djukanovic, Yike Guo, Sharon Mumby, Ian M. Adcock, Kian Fan Chung

Summary: By analyzing gene signatures of MC activation, we can identify phenotypes of severe asthma and indicate that MCs can have distinct transcriptional phenotypes associated with specific clinical phenotypes.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2022)

Article Respiratory System

Urinary metabotype of severe asthma evidences decreased carnitine metabolism independent of oral corticosteroid treatment in the U-BIOPRED study

Stacey N. Reinke, Shama Naz, Romanas Chaleckis, Hector Gallart-Ayala, Johan Kolmert, Nazanin Z. Kermani, Angelica Tiotiu, David Broadhurst, Anders Lundqvist, Henric Olsson, Marika Strom, Asa M. Wheelock, Cristina Gomez, Magnus Ericsson, Ana R. Sousa, John H. Riley, Stewart Bates, James Scholfield, Matthew Loza, Frederic Baribaud, Per S. Bakke, Massimo Caruso, Pascal Chanez, Stephen J. Fowler, Thomas Geiser, Peter Howarth, Ildiko Horvath, Norbert Krug, Paolo Montuschi, Annelie Behndig, Florian Singer, Jacek Musial, Dominick E. Shaw, Barbro Dahlen, Sile Hu, Jessica Lasky-Su, Peter J. Sterk, Kian Fan Chung, Ratko Djukanovic, Sven-Erik Dahlen, Ian M. Adcock, Craig E. Wheelock

Summary: This study investigates the impact of asthma severity and medication on metabolic processes using metabolomics analysis. The results reveal dysregulated metabolism in severe asthma, with differences observed between OCS-treated and non-treated patients. Altered carnitine metabolism is associated with mitochondrial dysfunction in severe asthma and is independent of OCS treatment.

EUROPEAN RESPIRATORY JOURNAL (2022)

Article Medicine, Research & Experimental

Airway epithelial dysfunction and mesenchymal transition in chronic obstructive pulmonary disease: Role of Oct-4

Rosalia Gagliardo, Fabio Bucchieri, Angela Marina Montalbano, Giusy Daniela Albano, Delphine Gras, Alberto Fucarino, Roberto Marchese, Giulia Anzalone, Chiara Lo Nigro, Pascal Chanez, Mirella Profita

Summary: The airway epithelium plays a critical role in the pathophysiology of COPD, with dysregulation of Oct4, CD146, and CD105 expression induced by cigarette smoke exposure potentially exacerbating airway epithelial dysfunction and contributing to disease progression.

LIFE SCIENCES (2022)

Article Biochemistry & Molecular Biology

Using intracellular SCGB1A1-sorted, formalin-fixed club cells for successful transcriptomic analysis

Charlotte Vernisse, Aurelie Petit, Veronique Pantesco, Pascal Chanez, Delphine Gras, Edouard Tuaillon, Christophe Duperray, Isabelle Vachier, Said Assou, Arnaud Bourdin

Summary: This paper presents an optimized protocol for microarray analysis of intracellular target-sorted human bronchial club cells. The protocol includes fixation and permeabilization steps and the addition of RNase inhibitors to ensure the preservation of high-quality RNA. The results show successful cell sorting and the generation of a transcriptomic signature for club cells.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2022)

Article Biochemistry & Molecular Biology

Platelets Purification Is a Crucial Step for Transcriptomic Analysis

Mohamad Chebbo, Said Assou, Veronique Pantesco, Catherine Duez, Marie C. Alessi, Pascal Chanez, Delphine Gras

Summary: Platelet transcriptome analysis is important for identifying disease-specific molecular signatures, but contamination during platelet purification process can greatly alter the transcriptome results, emphasizing the need for strict precautions to avoid contamination.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Oncology

Clinical and transcriptomic features of persistent exacerbation-prone severe asthma in U-BIOPRED cohort

Uruj Hoda, Stelios Pavlidis, Aruna T. Bansal, Kentaro Takahashi, Sile Hu, Francois Ng Kee Kwong, Christos Rossios, Kai Sun, Pankaj Bhavsar, Matthew Loza, Frederic Baribaud, Pascal Chanez, Stephen J. Fowler, Ildiko Horvath, Paolo Montuschi, Florian Singer, Jacek Musial, Barbro Dahlen, Norbert Krug, Thomas Sandstrom, Dominic E. Shaw, Rene Lutter, Louise J. Fleming, Peter H. Howarth, Massimo Caruso, Ana R. Sousa, Julie Corfield, Charles Auffray, Bertrand De Meulder, Diane Lefaudeux, Sven-Erik Dahlen, Ratko Djukanovic, Peter J. Sterk, Yike Guo, Ian M. Adcock, Kian Fan Chung

Summary: This study examines the clinical and transcriptomic features of exacerbation-prone asthma and its persistence. The frequent exacerbators (FEs) and persistent FEs (PFEs) are associated with poor asthma control and exhibit higher expression scores of type 1 and type 2 activation pathways.

CLINICAL AND TRANSLATIONAL MEDICINE (2022)

Article Allergy

Efficacy and Safety of Masitinib in Corticosteroid-Dependent Severe Asthma: A Randomized Placebo-Controlled Trial

Lavinia Davidescu, Grigoriy Ursol, Oleksii Korzh, Vikranth Deshmukh, Lesia Kuryk, Monja-Marie Nortje, Olga Godlevska, Gilles Devouassoux, Eduard Khodosh, Elliot Israel, Alain Moussy, Colin Mansfield, Olivier Hermine, Pascal Chanez

Summary: Orally administered masitinib reduces the risk of asthma exacerbations in severe asthma patients and has an acceptable safety profile. It may potentially provide a new treatment option for oral corticosteroid-dependent severe asthma.

JOURNAL OF ASTHMA AND ALLERGY (2022)

Article Cell Biology

Mobilisation of HLA-F on the surface of bronchial epithelial cells and platelets in asthmatic patients

Sabrina Fiouane, Mohamad Chebbo, Sophie Beley, Julien Paganini, Christophe Picard, Xavier-Benoit D'journo, Pascal-Alexandre Thomas, Jacques Chiaroni, Pascal Chanez, Delphine Gras, Julie Di Cristofaro

Summary: Uncontrolled inflammation in chronic obstructive lung diseases, such as asthma, results in respiratory exacerbation and dysfunction. This study investigates the expression of HLA-F, a molecule involved in immune cell activation, in human bronchial epithelium cells (HBEC) and platelets (PLT). The results suggest that HLA-F is expressed in both cell types under healthy conditions and is upregulated in the context of asthma-associated inflammation. These findings highlight the potential therapeutic relevance of HLA-F in controlling lung inflammation.
Article Medicine, General & Internal

Diaphragm dysfunction after severe COVID-19: An ultrasound study

Alain Boussuges, Paul Habert, Guillaume Chaumet, Rawah Rouibah, Lea Delorme, Amelie Menard, Matthieu Million, Axel Bartoli, Eric Guedj, Marion Gouitaa, Laurent Zieleskiewicz, Julie Finance, Benjamin Coiffard, Stephane Delliaux, Fabienne Bregeon

Summary: This study found that 10% of patients had diaphragm dysfunction after severe COVID-19 pneumonia. These patients often experienced muscle pain and had a higher frequency of prior cardiothoracic or upper abdominal surgery. Pulmonary function testing showed a significant decrease in lung volumes and DLCO, and dyspnea scores were significantly increased. Most patients showed improvement in respiratory function after prolonged respiratory physiotherapy.

FRONTIERS IN MEDICINE (2022)

No Data Available